Skip to main content
Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
3.570
+0.210 (6.25%)
Dec 20, 2024, 4:00 PM EST - Market closed

Sight Sciences Revenue

Sight Sciences had revenue of $20.16M in the quarter ending September 30, 2024, with 0.74% growth. This brings the company's revenue in the last twelve months to $79.54M, down -3.99% year-over-year. In the year 2023, Sight Sciences had annual revenue of $81.06M with 13.63% growth.

Revenue (ttm)
$79.54M
Revenue Growth
-3.99%
P/S Ratio
2.23
Revenue / Employee
$371,696
Employees
214
Market Cap
181.19M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202381.06M9.73M13.63%
Dec 31, 202271.33M22.38M45.70%
Dec 31, 202148.96M21.32M77.12%
Dec 31, 202027.64M4.29M18.38%
Dec 31, 201923.35M15.82M210.07%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 304.34M
InfuSystem Holdings 132.78M
Nektar Therapeutics 93.14M
Alector 61.51M
BrainsWay 38.63M
Innate Pharma 36.20M
KORU Medical Systems 31.99M
EUDA Health Holdings 3.81M
Revenue Rankings

SGHT News

More News